Cited by 210Cytomegalovirus and herpesvirus researchDementia and Cognitive Impairment ResearchHerpesvirus Infections and Treatments

The DOI matches its Crossref record; 78 of the 81 references it cites were found in a registry or an index.

The Influence of Latent Viral Infection on Rate of Cognitive Decline over 4 Years

Open access
Aiello, Allison E., Haan, Mary N., Blythe, Lynn, Moore, Kari, Gonzalez, Jeffrey M., Jagust, William·2006·Journal of the American Geriatrics Society

Abstract

OBJECTIVES: To examine whether cytomegalovirus (CMV) and herpes simplex virus type‐1 (HSV‐1) are associated with cognitive decline over a 4‐year period and to assess whether C‐reactive protein (CRP) modifies these relationships. DESIGN: Prospective cohort study over a 4‐year period. SETTING: Community‐dwelling elderly population. PARTICIPANTS: The sample was a subset (1,204/1,789) of participants in the Sacramento Area Latino Study on Aging (SALSA) aged 60 to 100. MEASUREMENTS: Participants were screened annually over a 4‐year period for cognitive function and episodic memory. Cognitive function was assessed using the modified Mini‐Mental State Examination, and episodic memory was assessed using a word list‐learning test of delayed recall. Baseline serum samples were assayed for levels of immunoglobulin G antibodies to CMV and HSV‐1 and for levels of CRP. RESULTS: There was a significantly higher rate of cognitive decline over the 4‐year period in subjects with the highest CMV antibody levels at baseline than in individuals with the lowest levels (β=−0.053, standard error =0.018; P =.003), after controlling for age, sex, education, income, and chronic health conditions. There was no association between HSV‐1 antibody levels and cognitive decline. CRP did not modify the relationship between viral antibody levels and cognitive decline. CONCLUSION: This is the first study to show that individuals with higher levels of antibody to CMV experience a more‐rapid rate of cognitive decline than those with lower levels. Understanding the mechanisms by which CMV influences cognition may aid development of intervention strategies targeting infection, viral reactivation, and immune response over the life course.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1532-5415.2006.00796.x

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 81 references

Research works printed but not linked: 1

  1. Rawls W., 1985, Virology

Cited by

Sorted by citations

See all 210

Metadata

Authors
Aiello, A. E., Haan, M. N., Blythe, L., Moore, K., Gonzalez, J. M., & Jagust, W.
Affiliations
University of Michigan (US)
Corresponding author
Aiello, Allison E.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2006-07
Volume
54
Issue
7
Pages
1046-1054
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W1946070691
Cited by
210
References
81
Citations by year
2026: 7 · 2025: 9 · 2024: 10 · 2023: 11 · 2022: 14 · 2021: 14 · 2020: 8 · 2019: 10 · 2018: 11 · 2017: 7 · 2016: 10 · 2015: 16 · 2014: 11 · 2013: 14 · 2012: 12
FWCI
6.51
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Geriatrics Society (publishedVersion)
  • PubMed (publishedVersion)
  • Deep Blue (University of Michigan) (submittedVersion)
Funders
  • National Institutes of Health (DK20572)
  • National Institute on Aging (AG-12975, R01AG012975, R03AG033751)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-60753, P60DK020572, NIH5P60, R01DK060753)
Topics
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
Keywords
cytomegalovirus, herpes simplex virus type 1, viral latency, cognitive decline, C-reactive protein, immunoglobulin G antibodies, episodic memory, older adults, aging, viral reactivation, immune response
MeSH terms
Aged, Aged, 80 and over, Antibodies, Viral, C-Reactive Protein, California, Cognition Disorders, Cytomegalovirus Infections, Dose-Response Relationship, Immunologic, Female, Herpes Simplex, Humans, Immunoglobulin G, Male, Middle Aged, Prospective Studies, Time Factors, Effect Modifier, Epidemiologic, Mexican Americans, Herpesvirus 1, Human

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review